Key Insights

Highlights

Success Rate

98% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.6%

1 terminated out of 62 trials

Success Rate

97.9%

+11.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

17%

8 of 47 completed with results

Key Signals

8 with results98% success

Data Visualizations

Phase Distribution

62Total
Not Applicable (11)
Early P 1 (4)
P 1 (45)
P 2 (2)

Trial Status

Completed47
Recruiting10
Not Yet Recruiting4
Terminated1

Trial Success Rate

97.9%

Benchmark: 86.5%

Based on 47 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT06911320Phase 1CompletedPrimary

Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function

NCT07314346Phase 1RecruitingPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Buprenorphine/Naloxone or Methadone

NCT07660731Phase 1RecruitingPrimary

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

NCT07511400Early Phase 1Completed

The Role of NaV1.8 in Human Pain Models

NCT07628465Not ApplicableCompletedPrimary

Differential Learning Enhances Motor Performance and Retention in Sport Science Students

NCT07021079Not ApplicableRecruiting

Muscle Vibration as a Countermeasure Against Hypoactivity-induced

NCT07600814Early Phase 1Not Yet Recruiting

Pain Induced by m-Cresol as Preservative

NCT05847322Not ApplicableRecruitingPrimary

Periscope Phase C Bordetella Pertussis Human Challenge Study With Delayed Antibiotic Therapy for 6 Weeks

NCT07272889Phase 1CompletedPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG)

NCT06636500Phase 1CompletedPrimary

A Phase 1 Study of CG001419 Administered Orally in Healthy Subjects

NCT06825364Not ApplicableRecruiting

Near-InfraRed Spectroscopy of Auricular Stimulation

NCT06608433Not ApplicableCompletedPrimary

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

NCT06983730Early Phase 1Recruiting

The Kidney's Response to Exercise in Heat, and the Impact of Vitamin B3 on This Response

NCT06757738Phase 1CompletedPrimary

A Clinical Study Aiming to Assess Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of TRX-100 in Healthy Volunteers

NCT06741345Phase 1CompletedPrimary

Phase 1 BIO 300 Oral Suspension

NCT05881993Early Phase 1CompletedPrimary

Study of CBP-4888 in Healthy, Non-Pregnant Female Subjects

NCT07007806Phase 1CompletedPrimary

Drug-drug Interaction Study of Omeprazole and Bemnifosbuvir/Ruzasvir

NCT06921941Phase 1CompletedPrimary

Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Digoxin and Rosuvastatin

NCT07099612Not ApplicableCompletedPrimary

Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usability Study

NCT06959888Phase 1CompletedPrimary

A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations

Scroll to load more

Research Network

Activity Timeline